Tapewire

Nasdaq · USD

QURE

uniQure N.V.

Export transactions ↓
Tapewire entity
4162
SEC CIK
0001590560
Parsed reports
431

Last 12 months

Inside the activity.

0 purchase rows · 57 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202500
Jan 202604
Feb 202602
Mar 202608
Apr 202600
May 202602
Jun 2026033
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2020 Filed Mar 2, 2020 20:43 UTC GrantStock Option (Right to Buy) · Derivative 3,620 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000255 · edgar.xml · derivative · entry 2

Astley-Sparke Philip · CIK 0001376491 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,620

Underlying: Ordinary Shares · 3,620 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:43 UTC GrantOrdinary Shares 2,063 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000255 · edgar.xml · nonDerivative · entry 1

Astley-Sparke Philip · CIK 0001376491 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,068

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:41 UTC
Kaye JackDirector
GrantStock Option (Right to Buy) · Derivative 3,620 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000253 · edgar.xml · derivative · entry 2

Kaye Jack · CIK 0001376099 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,620

Underlying: Ordinary Shares · 3,620 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:41 UTC
Kaye JackDirector
GrantOrdinary Shares 2,063 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000253 · edgar.xml · nonDerivative · entry 1

Kaye Jack · CIK 0001376099 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,191

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 21:01 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
GrantStock Option (Right to Buy) · Derivative 59,278 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000267 · edgar.xml · derivative · entry 2

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,278

Underlying: Ordinary Shares · 59,278 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 21:01 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
GrantOrdinary Shares 33,789 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000267 · edgar.xml · nonDerivative · entry 1

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,542

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 15:38 UTC
van Deventer SanderEVP, Research & Product Dev.
GrantStock Option (Right to Buy) · Derivative 21,719 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000251 · edgar.xml · derivative · entry 3

van Deventer Sander · CIK 0001543084 · EVP, Research & Product Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,719

Underlying: Ordinary Shares · 21,719 shares

Expires 2030-02-27

F3 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 15:38 UTC
van Deventer SanderEVP, Research & Product Dev.
GrantOrdinary Shares 12,380 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000251 · edgar.xml · nonDerivative · entry 1

van Deventer Sander · CIK 0001543084 · EVP, Research & Product Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,599

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:54 UTC GrantStock Option (Right to Buy) · Derivative 3,620 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000263 · edgar.xml · derivative · entry 2

Meek David D. · CIK 0001555337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,620

Underlying: Ordinary Shares · 3,620 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:54 UTC GrantOrdinary Shares 2,063 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000263 · edgar.xml · nonDerivative · entry 1

Meek David D. · CIK 0001555337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,571

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:52 UTC GrantStock Option (Right to Buy) · Derivative 3,620 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000261 · edgar.xml · derivative · entry 2

Balachandran Madhavan · CIK 0001555508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,620

Underlying: Ordinary Shares · 3,620 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:52 UTC GrantOrdinary Shares 2,063 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000261 · edgar.xml · nonDerivative · entry 1

Balachandran Madhavan · CIK 0001555508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,068

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 21:12 UTC
KLEMT CHRISTIANChief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 14,479 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000273 · edgar.xml · derivative · entry 2

KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,479

Underlying: Ordinary Shares · 14,479 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 21:12 UTC
KLEMT CHRISTIANChief Accounting Officer
GrantOrdinary Shares 8,253 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000273 · edgar.xml · nonDerivative · entry 1

KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,018

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 21:08 UTC
Kuta Alexander Edward IIIExecutive VP, Operations
GrantStock Option (Right to Buy) · Derivative 21,719 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000271 · edgar.xml · derivative · entry 2

Kuta Alexander Edward III · CIK 0001696698 · Executive VP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,719

Underlying: Ordinary Shares · 21,719 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 21:08 UTC
Kuta Alexander Edward IIIExecutive VP, Operations
GrantOrdinary Shares 12,380 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000271 · edgar.xml · nonDerivative · entry 1

Kuta Alexander Edward III · CIK 0001696698 · Executive VP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,090

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 21:05 UTC
Gut RobertDirector · Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 21,719 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000269 · edgar.xml · derivative · entry 2

Gut Robert · CIK 0001716268 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,719

Underlying: Ordinary Shares · 21,719 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 21:05 UTC
Gut RobertDirector · Chief Medical Officer
GrantOrdinary Shares 12,380 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000269 · edgar.xml · nonDerivative · entry 1

Gut Robert · CIK 0001716268 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,875

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:59 UTC GrantStock Option (Right to Buy) · Derivative 3,620 $0.00 Strike: $51.81 $0.00
Disclosure

SEC source: 0000904454-20-000265 · edgar.xml · derivative · entry 2

Springhorn Jeremy P. · CIK 0001717852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,620

Underlying: Ordinary Shares · 3,620 shares

Expires 2030-02-27

F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:59 UTC GrantOrdinary Shares 2,063 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000265 · edgar.xml · nonDerivative · entry 1

Springhorn Jeremy P. · CIK 0001717852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,068

F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Read SEC document
February 19, 2020 Filed Feb 21, 2020 15:03 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 200 $65.63 $13,126.00
Disclosure

SEC source: 0000904454-20-000222 · edgar.xml · nonDerivative · entry 4

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,753

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.70 to $65.75. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 19, 2020 Filed Feb 21, 2020 15:03 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 4,801 $65.06 $312,353.06
Disclosure

SEC source: 0000904454-20-000222 · edgar.xml · nonDerivative · entry 3

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,953

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.70 to $65.64. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 19, 2020 Filed Feb 21, 2020 15:03 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 900 $64.33 $57,897.00
Disclosure

SEC source: 0000904454-20-000222 · edgar.xml · nonDerivative · entry 2

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,754

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.70 to $64.68. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 19, 2020 Filed Feb 21, 2020 15:03 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 1,600 $63.05 $100,880.00
Disclosure

SEC source: 0000904454-20-000222 · edgar.xml · nonDerivative · entry 1

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,654

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.67 to $63.62. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 05, 2020 Filed Feb 5, 2020 18:19 UTC SaleOrdinary Shares 822 $61.53 $50,577.66
Disclosure

SEC source: 0000904454-20-000154 · edgar.xml · nonDerivative · entry 2

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,423

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.13 to $61.85. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 05, 2020 Filed Feb 5, 2020 18:19 UTC SaleOrdinary Shares 1,300 $60.58 $78,754.00
Disclosure

SEC source: 0000904454-20-000154 · edgar.xml · nonDerivative · entry 1

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,245

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.10 to $60.97. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 31, 2020 Filed Jan 31, 2020 16:13 UTC
van Deventer SanderEVP, Research & Product Dev.
GrantOrdinary Shares 6,092 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000132 · edgar.xml · nonDerivative · entry 1

van Deventer Sander · CIK 0001543084 · EVP, Research & Product Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,219

F1 · shares: Represents performance-based restricted share units ("PRSUs") granted on January 25, 2019 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 31, 2020. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
January 31, 2020 Filed Jan 31, 2020 22:10 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
GrantOrdinary Shares 27,713 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000146 · edgar.xml · nonDerivative · entry 1

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,254

F1 · shares: Represents performance-based restricted share units ("PRSUs") granted on January 25, 2019 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 31, 2020. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
January 31, 2020 Filed Jan 31, 2020 20:45 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 3,872 $57.98 $224,498.56
Disclosure

SEC source: 0000904454-20-000126 · edgar.xml · nonDerivative · entry 8

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,541

F9 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.62 to $58.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 31, 2020 Filed Jan 31, 2020 21:09 UTC
KLEMT CHRISTIANChief Accounting Officer
GrantOrdinary Shares 6,201 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000130 · edgar.xml · nonDerivative · entry 1

KLEMT CHRISTIAN · CIK 0001711885 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,765

F1 · shares: Represents performance-based restricted share units ("PRSUs") granted on January 25, 2019 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 31, 2020. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
January 31, 2020 Filed Jan 31, 2020 21:05 UTC
Kuta Alexander Edward IIIExecutive VP, Operations
GrantOrdinary Shares 6,610 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000128 · edgar.xml · nonDerivative · entry 1

Kuta Alexander Edward III · CIK 0001696698 · Executive VP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,710

F1 · shares: Represents performance-based restricted share units ("PRSUs") granted on January 25, 2019 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 31, 2020. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
January 31, 2020 Filed Jan 31, 2020 21:17 UTC
Gut RobertDirector · Chief Medical Officer
GrantOrdinary Shares 5,610 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000136 · edgar.xml · nonDerivative · entry 1

Gut Robert · CIK 0001716268 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,495

F1 · shares: Represents performance-based restricted share units ("PRSUs") granted on January 25, 2019 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 31, 2020. Each PRSU represents the contingent right to receive one Ordinary Share.

Read SEC document
January 30, 2020 Filed Jan 31, 2020 02:39 UTC SaleOrdinary Shares 807 $59.23 $47,798.61
Disclosure

SEC source: 0000904454-20-000124 · edgar.xml · nonDerivative · entry 1

Astley-Sparke Philip · CIK 0001376491 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,005

F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

Read SEC document
January 30, 2020 Filed Jan 31, 2020 20:45 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 300 $61.11 $18,333.00
Disclosure

SEC source: 0000904454-20-000126 · edgar.xml · nonDerivative · entry 7

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,413

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.02 to $61.27. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 30, 2020 Filed Jan 31, 2020 20:45 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 2,354 $60.58 $142,605.32
Disclosure

SEC source: 0000904454-20-000126 · edgar.xml · nonDerivative · entry 6

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,713

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.15 to $60.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 30, 2020 Filed Jan 31, 2020 20:45 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 11,744 $59.45 $698,180.80
Disclosure

SEC source: 0000904454-20-000126 · edgar.xml · nonDerivative · entry 5

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,067

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.14 to $60.12. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 30, 2020 Filed Jan 31, 2020 20:45 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 9,185 $58.74 $539,526.90
Disclosure

SEC source: 0000904454-20-000126 · edgar.xml · nonDerivative · entry 4

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,811

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.14 to $59.13. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 29, 2020 Filed Jan 31, 2020 20:45 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 600 $62.89 $37,734.00
Disclosure

SEC source: 0000904454-20-000126 · edgar.xml · nonDerivative · entry 3

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,996

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.81 to $63.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 29, 2020 Filed Jan 31, 2020 20:45 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 18,383 $62.01 $1,139,929.83
Disclosure

SEC source: 0000904454-20-000126 · edgar.xml · nonDerivative · entry 2

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,596

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.79 to $62.76. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 29, 2020 Filed Jan 31, 2020 20:45 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 4,600 $61.55 $283,130.00
Disclosure

SEC source: 0000904454-20-000126 · edgar.xml · nonDerivative · entry 1

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,979

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.79 to $61.77. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 28, 2020 Filed Jan 29, 2020 16:24 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 1,400 $62.80 $87,920.00
Disclosure

SEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 7

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,579

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.73 to $63.13. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 28, 2020 Filed Jan 29, 2020 16:24 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 11,707 $62.42 $730,750.94
Disclosure

SEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 6

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,979

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.73 to $62.72. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 28, 2020 Filed Jan 29, 2020 16:24 UTC
Kapusta Matthew CDirector · CEO, CFO, Managing Director
SaleOrdinary Shares 10,476 $61.24 $641,550.24
Disclosure

SEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 5

Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,686

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.73 to $61.70. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 28, 2020 Filed Jan 29, 2020 23:02 UTC
Gut RobertChief Medical Officer
SaleOrdinary Shares 596 $62.19 $37,065.24
Disclosure

SEC source: 0000904454-20-000090 · edgar.xml · nonDerivative · entry 2

Gut Robert · CIK 0001716268 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,885

F2 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F2 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

Read SEC document
January 28, 2020 Filed Jan 30, 2020 21:06 UTC SaleOrdinary Shares 806 $62.27 $50,189.62
Disclosure

SEC source: 0000904454-20-000112 · edgar.xml · nonDerivative · entry 1

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,915

F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.50 to $62.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 28, 2020 Filed Jan 31, 2020 02:15 UTC SaleOrdinary Shares 807 $62.19 $50,187.33
Disclosure

SEC source: 0000904454-20-000116 · edgar.xml · nonDerivative · entry 1

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,545

F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.46 to $62.20. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 28, 2020 Filed Jan 31, 2020 02:36 UTC
Kuta Alexander Edward IIIExecutive VP, Operations
SaleOrdinary Shares 1,469 $62.15 $91,298.35
Disclosure

SEC source: 0000904454-20-000122 · edgar.xml · nonDerivative · entry 2

Kuta Alexander Edward III · CIK 0001696698 · Executive VP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,100

F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.04 to $62.33. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 28, 2020 Filed Jan 31, 2020 02:36 UTC
Kuta Alexander Edward IIIExecutive VP, Operations
SaleOrdinary Shares 9 $61.08 $549.72
Disclosure

SEC source: 0000904454-20-000122 · edgar.xml · nonDerivative · entry 1

Kuta Alexander Edward III · CIK 0001696698 · Executive VP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,569

F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.88 to $61.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 28, 2020 Filed Jan 31, 2020 02:32 UTC
Kaye JackDirector
SaleOrdinary Shares 806 $62.20 $50,133.20
Disclosure

SEC source: 0000904454-20-000120 · edgar.xml · nonDerivative · entry 1

Kaye Jack · CIK 0001376099 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,128

F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

Read SEC document
January 28, 2020 Filed Jan 30, 2020 21:11 UTC
van Deventer SanderEVP, Research & Product Dev.
SaleOrdinary Shares 923 $62.10 $57,318.30
Disclosure

SEC source: 0000904454-20-000114 · edgar.xml · nonDerivative · entry 2

van Deventer Sander · CIK 0001543084 · EVP, Research & Product Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,127

F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.85 to $61.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.